4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0000950170-25-049581
Chief Financial Officer sold 10,896 shares at $3.47 ($37,806)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| FRATES JAMES M Chief Financial Officer | 2025-03-31 | Sale | −10,896 | $3.47 | $37,806 | 290,988 | D |
| Open-market sales · 10,896 sh · avg $3.47 · $37,806 | |||||||
Loading xslF345X05/ownership.xml…